Stock Market Stories and Insights

It looks like 3M will be up for a correction way faster as its share price whent up 1.72% today to Plains All's 0.8651%. As many of us are excited about energy space, we will review both, Plains All and 3M as a potential short-term opportunity. We are going to analyze some of the competitive aspects of both Plains and 3M.
  over a month ago at Macroaxis 
By Raphi Shpitalnik
Raphi Shpitalnik
Today we may see the proof that Salesforce would recover much slower from the new pull down as its shares went up 1.69% to Embark Technology's 84.4828%. As many rational traders are trying to avoid technology space, it makes sense to examine Embark Technology a little further and understand how it stands against Salesforce and other similar entities. We are going to concentrate on some of the competitive aspects of both Embark and Salesforce.
  over a month ago at Macroaxis 
By Vlad Skutelnik
Vlad Skutelnik
Coca Cola Tangible Asset Value is quite stable at the moment as compared to the past year. The company's current Tangible Asset Value is estimated at 67.35 Billion. Interest Coverage is expected to rise to 8.01 this year, although the value of Revenue Per Employee will most likely fall to about 425.6 K. There are many examples of prices sliding after a drastic change in one of the basic indicators. In this short article, we will outline a few of Coca Cola's essential fundamentals. I will address the reasons this entity was abused by institutional investors resulted from the current market uncertainty. The company current probability of distress is under 15 percent. Will institutional investors continue to be optimistic, or should we expect a sell-off?
  over a month ago at Macroaxis 
By Ellen Johnson
Ellen Johnson
The stock experiences above-average trading activities. While some of us are getting worried about consumer cyclical space, it is reasonable to break down Bed Bath Beyond using its current fundamental data. We will look into reasons why it is still very possible for the company to generate above-average returns. The entity current probability of bankruptcy is under 29 percent. Will investors continue to be optimistic, or should we expect a sell-off?
  over a month ago at Macroaxis 
By Gabriel Shpitalnik
Gabriel Shpitalnik
Casi Pharmaceuticals is scheduled to announce its earnings today. Casi Pharmaceuticals Enterprise Value is most likely to increase significantly in the upcoming years. The preceding year's Enterprise Value was reported at 59.8 Million. The current Invested Capital is estimated to increase to about 80.1 M, while Net Income Per Employee is projected to decrease to (224.7 K). While some baby boomers are getting worried about healthcare space, it is reasonable to concentrate on Casi Pharmaceuticals as an investment alternative.
  over a month ago at Macroaxis 
By Raphi Shpitalnik
Raphi Shpitalnik
Spectrum Brands Revenue Per Employee is projected to decrease significantly based on the last few years of reporting. The past year's Revenue Per Employee was at 375,734. The current year Earnings before Tax is expected to grow to about 385.6 M, whereas Net Income Per Employee is forecasted to decline to (2.6 M). As many of us are excited about consumer defensive space, it is fair to go over Spectrum Brands Holdings. We will evaluate why recent Spectrum Brands price moves suggest a bounce in September. Here I will also expose some primary fundamental factors affecting Spectrum Brands' services, and outline how it will impact the outlook for investors this year.
  over a month ago at Macroaxis 
By Gabriel Shpitalnik
Gabriel Shpitalnik
Plx Pharma is scheduled to announce its earnings today. As many millenniums are trying to avoid healthcare space, it makes sense to recap Plx Pharma a little further and try to understand its current market patterns. What exactly are Plx Pharma shareholders getting in September? Here we also measure the ability of Plx Pharma to meet its long-term debt obligations, such as interest payments on debt, the final principal payment on the debt, and any other fixed obligations like lease payments.
  over a month ago at Macroaxis 
By Ellen Johnson
Ellen Johnson
While some millenniums are indifferent towards consumer cyclical space, it makes sense to sum up China Automotive Sys in terms of its current potentials. As expected, China Automotive is starting to reaffirm its true potential as retail investors are becoming more and more confident in the future outlook. The returns on investing in China Automotive and the market returns of the last few months appear uncorrelated to each other. The record of invariable basic indicators of the enterprise connotes a short-term price swing for retail investors of China. China Automotive Sys is scheduled to announce its earnings today.
  over a month ago at Macroaxis 
By Vlad Skutelnik
Vlad Skutelnik
Bio-Key Intl is scheduled to announce its earnings today. While some baby boomers are getting worried about their positions in industrials space, it is entirely reasonable to concentrate on Bio-Key Intl as a possible position for your existing portfolio. What exactly are Bio-Key Intl shareholders getting in September?
  over a month ago at Macroaxis 
By Vlad Skutelnik
Vlad Skutelnik
Casi Pharmaceuticals is scheduled to announce its earnings today. As many retail investors are getting excited about healthcare space, it is fair to concentrate on Casi Pharmaceuticals outlook under the current economic conditions. What exactly are Casi Pharmaceuticals shareholders getting in September?
  over a month ago at Macroaxis 
By Ellen Johnson
Ellen Johnson